Free Trial
NASDAQ:CGNT

Cognyte Software (CGNT) Stock Price, News & Analysis

$7.61
+0.10 (+1.33%)
(As of 07/26/2024 ET)
Today's Range
$7.49
$7.63
50-Day Range
$7.34
$8.13
52-Week Range
$4.00
$8.70
Volume
142,528 shs
Average Volume
344,296 shs
Market Capitalization
$540.46 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.25

Cognyte Software MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
8.4% Upside
$8.25 Price Target
Short Interest
Healthy
0.76% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.83
Upright™ Environmental Score
News Sentiment
1.14mentions of Cognyte Software in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.31) to ($0.24) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.66 out of 5 stars

Computer And Technology Sector

363rd out of 612 stocks

Prepackaged Software Industry

118th out of 202 stocks

CGNT stock logo

About Cognyte Software Stock (NASDAQ:CGNT)

Cognyte Software Ltd. provides an investigative analytics software to governments and enterprises worldwide. Its Actionable Intelligence for a Safer World, an open software designed to help governments and enterprises accelerate and enhance the effectiveness of investigations. The company offers network intelligence analytics, threat intelligence analytics, decision intelligence analytics, and operational intelligence analytics solutions. Its solutions are designed to support various use cases and support a range of users, including data analysts, investigation managers, and security operations center operators, as well as operational field teams. In addition, the company provides customer support, professional, and integration services. Its government customers include national, regional, and local government agencies. Cognyte Software Ltd. was incorporated in 2020 and is headquartered in Herzliya, Israel.

CGNT Stock Price History

CGNT Stock News Headlines

Cognyte Software (NASDAQ:CGNT) Shares Gap Down to $7.44
625,000% Gain
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
625,000% Gain
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
Cognyte: Appears Fully Valued, Hold For Now
Cognyte Software Ltd Ordinary Shares
See More Headlines
Receive CGNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cognyte Software and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
6/18/2024
Today
7/26/2024
Next Earnings (Estimated)
9/10/2024
Fiscal Year End
1/31/2025

Industry, Sector and Symbol

Industry
Prepackaged software
Sub-Industry
N/A
Current Symbol
NASDAQ:CGNT
Fax
N/A
Employees
1,613
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$8.25
High Stock Price Target
$9.00
Low Stock Price Target
$7.50
Potential Upside/Downside
+8.3%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
3 Analysts

Profitability

Net Income
$-15,570,000.00
Pretax Margin
-2.86%

Debt

Sales & Book Value

Annual Sales
$313.40 million
Book Value
$3.12 per share

Miscellaneous

Free Float
26,492,000
Market Cap
$541.17 million
Optionable
Optionable
Beta
1.74
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Elad Sharon (Age 47)
    CEO & Director
    Comp: $1.72M
  • Mr. David Abadi (Age 49)
    Chief Financial Officer
    Comp: $1.08M
  • Mr. Sharon Chouli (Age 53)
    Chief Customer Officer
    Comp: $780k
  • Mr. Amir Barel (Age 58)
    Chief Technology Officer
  • Mr. Dean M. Ridlon
    Head of Investor Relations
  • Mr. Ilan Rotem (Age 58)
    Chief Legal Officer
  • Ms. Rini Karlin (Age 52)
    Chief People Officer
  • Mr. Gil Cohen (Age 52)
    Chief Product Officer
  • Mr. Efi Nuri (Age 61)
    Chief Revenue Officer

CGNT Stock Analysis - Frequently Asked Questions

How have CGNT shares performed this year?

Cognyte Software's stock was trading at $6.43 at the start of the year. Since then, CGNT shares have increased by 18.4% and is now trading at $7.61.
View the best growth stocks for 2024 here
.

How were Cognyte Software's earnings last quarter?

Cognyte Software Ltd. (NASDAQ:CGNT) announced its quarterly earnings results on Tuesday, June, 18th. The medical device company reported ($0.04) EPS for the quarter, topping the consensus estimate of ($0.07) by $0.03. The company's revenue was up 12.7% compared to the same quarter last year.

Who are Cognyte Software's major shareholders?

Top institutional shareholders of Cognyte Software include ARK Investment Management LLC (0.47%), Silverberg Bernstein Capital Management LLC (0.14%) and DT Investment Partners LLC (0.01%).
View institutional ownership trends
.

How do I buy shares of Cognyte Software?

Shares of CGNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Cognyte Software own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Cognyte Software investors own include EndoChoice (GI), Novavax (NVAX), Sorrento Therapeutics (SRNE), Exelixis (EXEL), Fc Global Realty (FCRE), Galectin Therapeutics (GALT) and Immunomedics (IMMU).

This page (NASDAQ:CGNT) was last updated on 7/27/2024 by MarketBeat.com Staff

From Our Partners